WebProfessors Chiara Falciani and Alessandro Pini report a patent, WO20101038220, licensed to Setlance. Dr Iraida Loinaz, Dr Raquel Gracia and Professor Marco Marradi report a patent, EP3215545B1, licensed to Kusudama Therapeutics. At the time of the study, Giulia Riolo was employed by SetLance srl, and Marco Marradi by CIDETEC. Web20 Dec 2024 · Europe PMC is an archive of life sciences journal literature.
Isomerization of an Antimicrobial Peptide Broadens Antimicrobial ...
WebSetLance srl Vibiosphen Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Laboratory of Molecular Bioengineering G. N. Gabrichevsky Moscow Research Institute for Epidemiology and Microbiology, The Russian Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing WebSetLance is a biotech company focused on the development of peptide-based drugs. It was founded in 2009 by Luisa Bracci, Chiara Falciani and Alessandro Pini, researchers at the … SetLance srl SetLance exploits a tetra-branched or di-branched peptide format … SetLance srl SetLance activity is currently based on: 1) identification, production, … Horizon Europe (HORIZON) Marie Skłodowska-Curie Actions Doctoral … SetLance finances a PhD position in Biochemistry and Molecular Biology - … SetLance srl SetLance shareholders are: Luisa Bracci, Ph.D. She is presently Full … SetLance finances a PhD position in Biochemistry and Molecular Biology – … 29th European Congress of Clinical Microbiology and Infectious Diseases - … The article ''A new hope for treating severe pneumonia'' featuring Setlance's … ethically organic
A new hope for treating severe pneumonia - Medical Xpress
Web2 Dec 2015 · NT4 binding to ovarian and breast cancer cells. Binding of fluorophore-conjugated tetrabranched NT4 was tested in two human cell lines, namely SKOV-3 ovarian adenocarcinoma and MDA-MB 231 breast ... Web20 Nov 2024 · SetLance srl, Siena, Italy. Search for more papers by this author. Jlenia Brunetti, Jlenia Brunetti. Department of Medical Biotechnology, University of Siena, Siena, Italy. Search for more papers by this author. Giulia Riolo, Giulia Riolo. WebSetLance is a biotech company focusing its activity on the development of peptide-based drugs. It was founded in 2009 by Luisa Bracci, Chiara Falciani and Alessandro Pini, researchers at the University of Siena, Italy. SetLance has its registered offices at ToscanaLife Sciences campusin Siena. ethically open relationship